Denali Therapeutics Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Denali Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q4 2018 to Q3 2024.
  • Denali Therapeutics Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 169M shares, a 23.1% increase year-over-year.
  • Denali Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 137M shares, a 9.43% increase from 2022.
  • Denali Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 126M shares, a 3.3% increase from 2021.
  • Denali Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 122M shares, a 11.5% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 169M +31.8M +23.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 169M +31.8M +23.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 149M +12.9M +9.43% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 137M +11.8M +9.43% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 138M +14.2M +11.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 137M +14M +11.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 137M +13.9M +11.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 126M +4.01M +3.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 123M +1.73M +1.42% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 123M +1.72M +1.42% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 123M +1.79M +1.48% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 122M +12.6M +11.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 122M +14.3M +13.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 121M +15.6M +14.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 121M +18.5M +18% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 109M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 107M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 106M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 102M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2018 94.3M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.